XTLB
Xtl Biopharmaceuticals·NASDAQ
--
--(--)
--
--(--)
2.08 / 10
Underperform
Technical assessment is poor, scoring 2.08/10 and labeled Underperform. Recent candlestick patterns show three bearish signals—long lower shadow, long upper shadow, and Marubozu White—against one neutral Dark Cloud Cover. Market momentum appears weak, indicating heightened downside risk.
Analysis Checks(0/4)
Long Lower Shadow
Score1/10
Win Rate38.55%
Hist. Signals83
Avg Return-0.99%
Score1/10
Win Rate38.55%
Hist. Signals83
Avg Return-0.99%
Dark Cloud Cover
Score4.14/10
Win Rate50.00%
Hist. Signals6
Avg Return0.68%
Score4.14/10
Win Rate50.00%
Hist. Signals6
Avg Return0.68%
Long Upper Shadow
Score1/10
Win Rate36.00%
Hist. Signals75
Avg Return-1.68%
Score1/10
Win Rate36.00%
Hist. Signals75
Avg Return-1.68%
Marubozu White
Score2.2/10
Win Rate44.74%
Hist. Signals38
Avg Return-0.03%
Score2.2/10
Win Rate44.74%
Hist. Signals38
Avg Return-0.03%
Long Lower Shadow
Score1/10
Win Rate38.55%
Hist. Signals83
Avg Return-0.99%
Score1/10
Win Rate38.55%
Hist. Signals83
Avg Return-0.99%
Long Upper Shadow
Score1/10
Win Rate36.00%
Hist. Signals75
Avg Return-1.68%
Score1/10
Win Rate36.00%
Hist. Signals75
Avg Return-1.68%
Dark Cloud Cover
Score4.14/10
Win Rate50.00%
Hist. Signals6
Avg Return0.68%
Score4.14/10
Win Rate50.00%
Hist. Signals6
Avg Return0.68%
Marubozu White
Score2.2/10
Win Rate44.74%
Hist. Signals38
Avg Return-0.03%
Score2.2/10
Win Rate44.74%
Hist. Signals38
Avg Return-0.03%
Technical Analysis of XTLB?
- XTLB presents a Underperform setup with a Technical Score of 2.08/10. Key technical indicators highlight an RSI of 43.22 and a MACD of 0.00, with the trend anchored by the 50-Day SMA at 0.82. Traders should monitor key support at 0.57 and resistance at 0.60.
